Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

NCT04656704 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04656704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Withdrawn
Start date
January 1, 2020
Completion date
January 1, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crest syndrome, microstomia, morphea, scleroderma, scleromyxedema